2022
DOI: 10.3389/fendo.2022.1017177
|View full text |Cite
|
Sign up to set email alerts
|

Higher plasma aldosterone is associated with increased risk of cardiovascular events in hypertensive patients with suspected OSA: UROSAH data

Abstract: ObjectiveTo evaluate the association of plasma aldosterone concentration (PAC) with incident cardiovascular disease (CVD) and all-cause mortality in hypertensive patients with suspected obstructive sleep apnea (OSA) and calculate the optimal cut-off value of PAC for this specific population.Patients and methodsParticipants with PAC at baseline in UROSAH in 2011-2013 were enrolled and followed up till 2021. Composite outcome included CVD and all-cause mortality. Cox proportional hazards model was used to evalua… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 38 publications
0
2
0
Order By: Relevance
“…Data were obtained from the UROSAH study. The design and data collection of the UROSAH study have been described in detail elsewhere ( 24 26 ). Briefly, UROSAH is a single-center observational study to assess the association of OSA with long term cardiovascular outcomes in patients with HTN.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Data were obtained from the UROSAH study. The design and data collection of the UROSAH study have been described in detail elsewhere ( 24 26 ). Briefly, UROSAH is a single-center observational study to assess the association of OSA with long term cardiovascular outcomes in patients with HTN.…”
Section: Methodsmentioning
confidence: 99%
“…All events were certified by medical documents and confirmed by the clinical event committee. Details were described in previous studies ( 24 26 ).…”
Section: Methodsmentioning
confidence: 99%